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d Empresa Brasileira de Pesquisa Agropecuária - Embrapa, PqEB, W3 Norte - Asa Norte, Brasília, DF, Brazil 
e Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil 
f Post-Graduate Program in Biotechnology, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil   
A R T I C L E  I N F O   
Keywords: 
Macauba 
Lauric acid 
Cholesterol 
Insulin resistance 
Diabetes 
Hyperglycemia 
A B S T R A C T   
This study evaluated the effects of dietaries formulated with kernel oil of Acrocomia aculeata (AKO), rich in 
medium chain fatty acids (MCFA), as partial substitute of carbohydrate calories upon blood glucose, lipid profile, 
insulin secretion and insulin sensitivity in diabetic rats. Overall, the dietary with any AKO dose reduced hy-
perglycemia, ameliorated insulin secretion, lowered insulin resistance by model HOMA-IR and HOMA-β and 
augmented pancreatic beta cells functionality, restored the number of pancreatic β-cell in the diabetic rats and 
increased it in the non-diabetic rats. In addition, AKO fed rats showed reducing triglycerides, lower density 
lipoprotein-cholesterol and increasing high density lipoprotein-cholesterol levels, and improved hepatic function 
markers. Those findings suggest AKO was effective to ameliorate the health of diabetic rats.   
1. Introduction 
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease 
which arises from complex interactions between multiple genetic and 
environmental factors as well as due to one’s lifestyle. T2DM is char-
acterized by either high blood glucose level (hyperglycemia), disorders 
in the metabolism of carbohydrates, lipids and proteins due to defective 
insulin secretion, or action or by both (American Diabetes Association, 
2020; International Diabetes Federation, 2019; Bene, Hadzsiev, & 
Melegh, 2018; Subramanian & Prasath, 2014). 
The worldwide increase of diabetes is a public health issue. Ac-
cording to the International Diabetes Federation, there is an 8.3 percent 
global prevalence among adults (aged 20–79years), which translates to 
463 million adults having diabetes in 2019. These numbers are 
predicted to increase 9.6 percent by 2045, reaching 700 million adults 
(International Diabetes Federation, 2019). Brazil has 16.8 million peo-
ple affected by T2DM, which accounts for 8.0 percent of the total pop-
ulation. This ranks Brazil in fifth for the countries with the largest 
prevalence of case worldwide, and in first among South and Central 
American countries (International Diabetes Federation, 2019). 
Most patients with T2DM cannot maintain long-term glycemic levels 
under control. Several approaches have been applied in order to stabi-
lize these levels, such as suitable diet and physical exercise and the use of 
hypoglycemic drugs in more severe cases. However, such drugs can 
cause several side effects (Veerapur, Prabhakar, Kandadi, Srinivasan, & 
Unnikrishnan, 2010). Therefore, the demand for new antidiabetic drugs 
and treatment approaches is increasing, especially for nutraceuticals 
with milder side effects and higher antidiabetic potential. 
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Pharmacological intervention with natural product-based ingredients is 
claimed as a healthier alternative to treat diabetes and could have 
greater effectiveness and lower cost. Products from the wild plant 
biodiversity have shown some effectiveness to treat diabetes in tradi-
tional medicine (Ngala, Ampong, Sakyi, & Anto, 2016; Kochikuzhyil, 
Devi, & Fattepur, 2010; Naskar et al., 2011; Freitas de Lima et al., 2017; 
Baldissera et al., 2017; da Silva et al., 2019). In our research group, we 
have been looking at alternative sources other than carbohydrates to 
supply energy as a strategy to mitigate the deleterious effects of T2DM. 
A promising source are the vegetable oils rich in medium chain fatty 
acids (MCFAs), meaning the fatty acids whose carboxylic chain is within 
6–12 carbons. Those fatty acids have been shown to improve factors 
associated with type 2 diabetes by lowering total cholesterol and density 
lipoprotein (LDL) levels, lowering aspartate transaminase (AST) activ-
ity, and lowering body weight (BW) and body mass index (BMC) (Air-
hart et al., 2016). The role MCFAs play is likely connected to their 
specific mechanisms of absorption, transport, and mitochondrial meta-
bolism, which diverges from long chain fatty acids. MCFAs have an 
entrance to the mitochondrial matrix that bypasses the chylomicrons 
lymphatic route and is independently the L-Carnitine mediated trans-
port, making it a unique fatty acid. Additionally, the transport is not 
under L-malonyl-CoA metabolic control and the deposit in the adipose 
tissues is low (Bach & Babayan, 1982; Bremer, 1983; Marten, Pfeuffer, & 
Schrezenmeir, 2006; Schönfeld & Wojtczak, 2016). 
The metabolic pathways of MCFAs could explain their effects upon 
reduced adiposity and preserved insulin action in muscle and adipose 
tissue. This was observed in Wistar rats fed with a high fat diet rich in 
MCFAs 59% for 5 weeks, suggesting that this could prevent obesity and 
peripheral insulin resistance (Turner et al., 2009). 
Other reports on humans and rodents have shown the benefits of 
diets supplemented with a high proportion of MCFAs instead of LCFAs. 
Some benefits include more efficient energy expenditure, higher fatty 
acid oxidation, lower adiposity, reducing fasting insulin level and 
amelioration of insulin resistance (HOMA-IR) (St-Onge, Bourque, Jones, 
Ross, & Parsons, 2003; St-Onge, Ross, Parsons, & Jones, 2003; Shino-
hara, Ogawa, Kasai, & Aoyama, 2005; Han et al., 2007; St-Onge & 
Bosarge, 2008; Montgomery et al., 2013; Airhart et al., 2016; Sung, Liao, 
& Chien, 2018). 
Aiming to diversify the traditional vegetable oils portfolio, which are 
facing challenges due to environmental sustainability issues, non- 
traditional crops have arisen as promising sources. Macauba (Acroco-
mia ssp), for instance, is a palm tree native to tropical America found 
mostly in the wetlands (Pantanal) and Savannah like area (Cerrados) of 
Brazil (Henderson, Galeano, & Bernal, 1997). Its fruit yields pulp (APO) 
and kernel oils (AKO), whose fatty acid compositions are very distin-
guishable (Del Río et al., 2016). Lipid content of the kernel is around 
60% (dry matter basis) and its fatty acid composition encompasses 
59.9–75.6% saturated fatty acids. Among them, MCFAs accounts for 
approximately 50% of the total composition, and lauric acid (C12:0) is 
the most abundant, accounting for 32.0–45.4% (Coimbra & Jorge, 2012; 
Lescano et al., 2015; Del Río et al., 2016; Nunes et al., 2018; Magalhães, 
Tavares, & Nunes, 2020). 
Macauba palm is receiving great interest not only in Brazil, but also 
abroad due to its high oil yield and sustainable production systems (Lieb 
et al., 2019; Tilahun et al., 2019; Colombo, Berton, Diaz, & Ferrari, 
2018; Barbosa-Evaristo et al., 2018; de Lima, Carvalho, Meerow, & 
Manfrin, 2018; Moreira et al., 2018; Acrocomia Research Platform, 
2019). In addition to picking from natural groves, commercial planta-
tions of macauba are spreading in Brazil and in the near future, its oils 
will be available at large scale (Inocas, 2020; Soleá, 2020). 
Macauba kernel oil could be an alternative source or partial 
replacement of energy supply for individuals carrying T2DM syndrome. 
Our previous report with macauba oil showed that rats, induced to 
T2DM who had AKO added to the diet to replace partially the total 
calories from carbohydrates, presented: weight loss, lower MCFAs 
deposition in the epididymal adipose tissue, and reduced blood glucose 
level (Nunes et al., 2018). In the present study, the effect of AKO was 
further evaluated upon serum lipid profile, insulin secretion, and insulin 
sensitivity in diabetic rats induced by high fat diet and low dose 
streptozotocin. 
2. Material and methods 
2.1. Fruit harvest and oil extraction 
Ripen macauba fruits were collected directly from the bunch of 
macauba palm trees growing in Mato Grosso do Sul State, Central-West 
region of Brazil (22◦05′44.6′′S 55◦20′50.5′′W). The hard-coriaceous 
endocarp that covers the kernel was mechanically broken to deliver 
the kernel. The kernel oil was extracted by expeller press (Ecirtec Brand, 
Model MPE-40) followed by centrifugation at 1300g for 10 min (Quimis 
Brand, Model Q222TM104). This crude macauba kernel oil, from now 
on called AKO, was stored at − 20 ◦C in amber glass flask after N2 
bubbling. The AKO was characterized and used in the experimental 
diets. 
2.2. Profile of fatty acids in the diets and Acrocomia aculeata kernel oil 
The fatty acid methyl ester (FAME) composition was determined 
after converting the oil to fatty acid methyl esters as described by Nunes 
et al., 2018. Firstly, 2 mL of 7% boron fluoride (BF3) methanolic solu-
tion, and 1 mL of toluene were added to the oil. The mixture was then 
heated to 100 ◦C for 45 min, cooled down to room temperature, followed 
by the addition of 5 mL of water, 3 mL of hexane, and 300 mg of sodium 
sulphate. The mixture was stirred and left to settle, after which the top 
layer was injected into a GC (Agilent 6890N, California) to obtain in-
dividual peaks of fatty acid methyl esters. The GC was equipped with a 
flame ionization detector (FID) and a polar capillary column (HP 88, 
0.25 mm internal diameter, 100 m length, and 0.25 mm film in thick-
ness). Injector temperature was 225 ◦C and detector temperature was 
285 ◦C. The initial column temperature was kept at 160 ◦C for 3 min, 
then increased to 190 ◦C at 3 ◦C/min for 6 min, followed by an increase 
to 230 ◦C at 6 ◦C/min and for 12 min. Total run time was 37.67 min. 
Individual FAME peaks were identified comparing their relative reten-
tion times with individual FAME standard (Supelco C8-C22, 99% pure). 
For additional control, samples were spiked with methyl undecanoate as 
an internal standard. Readings were analyzed using the Agilent Tech-
nologies Chemstation A09.01 Software. 
2.3. Experimental animals 
Male albino Wistar rats (n = 50; weighing within 150–170 g) were 
purchased from the Animal Facility of the São Paulo University (USP), 
Ribeirão Preto, SP, Brazil. All procedures were performed in accordance 
with the Ethical Principles in Animal Research in the Guide for the Care 
and Use of Laboratory Animals (Concil, 2010). Animal maintenance 
followed the guidelines of the Committee on Animal Experiments of the 
Dom Bosco Catholic University whose Committee for Ethics in Animal 
Experimentation approved these experiments under protocol N◦ 003/ 
2015. The rats were housed in standard sanitized polypropylene cages 
containing paddy husk as bedding (2 rats/cage) and maintained under 
controlled conditions, temperature of 22 ± 2 ◦C and 12/12 h light–dark 
cycle. The animals were acclimatized for a week by being fed with 
standard laboratory rat chow (Nuvilab® CR-1, Nuvital, PR, Brazil) and 
water ad libitum. 
2.4. Induction of type 2 diabetes by high fat diet and low-dose 
streptozotocin 
The rats were allocated into two dietary regimens. Diabetes was 
induced by feeding with high fat diet - HFD (Table 1) (58% calories from 
fat - lard, 25% calories from protein and 17% calories from carbohydrate 
Â.A. Nunes et al.                                                                                                                                                                                                                                
Journal of Functional Foods xxx (xxxx) xxx
3
as the percentage of total kcal) (Srinivasan, Viswanad, Asrat, Kaul, & 
Ramarao, 2005). The nondiabetic rats were fed with a Standard diet 
(Table 1), as per the recommendations of the American Institute of 
Nutrition (AIN93M) (Reeves, Nielsen, & Fahey, 1993). Both groups were 
fed accordingly over three weeks. Afterwards, both groups were left 
fasting overnight (12 h). For induction of diabetes, in the HFD groups, a 
single low dose of streptozotocin (STZ) was administered intraperito-
neally. The STZ dose (Sigma-Aldrich, St. Louis, MO, USA. Ref S0130) 
involved 35 mg/kg body weight dissolved in freshly prepared sodium 
citrate buffer (0.1 M, pH 4.5). The vehicle was administered in the 
nondiabetic animals. After 6 h of STZ injection, the rats were fed again 
with their respective diet. In order to prevent fatal hypoglycemia, water 
was replaced by a 5% dextrose solution (Sigma-Aldrich, St. Louis, MO, 
USA. Ref. D9434) for the following 24 h. At the end of the fourth week, 
blood glucose level was measured in previously fasted animals (12 h), 
following the enzymatic glucose oxidase method using a commercial 
glucometer (Accu-Chek®Active, Roche Diagnostic, Mannheim, Ger-
many). Animals with blood glucose ≥250 mg/dL were considered dia-
betic and selected for the study. There was no death among the 
experimental groups along the assays. 
2.5. Experimental design 
The animals were randomly divided into five groups (eight rats each 
n = 8): 
Group (NC): Normal control received (Standard diet AIN93M); 
Group (DBC): Diabetic control received (Standard diet AIN93M); 
Group (DAL): Diabetic rats + AKO low dose (40 g of AKO kg− 1 of diet 
1); 
Group (DAH): Diabetic rats + AKO high dose (160 g of AKO kg− 1 of 
diet 2); 
Group (NAH): Non-diabetic rats +AKO high dose (160 g of AKO kg− 1 
of diet 2). 
Diets were developed by following the American Institute of Nutri-
tion (AIN93M) guides, exchanging the fat source, and providing partial 
replacement to the carbohydrate’s energy source with AKO, as described 
in (Table 1). 
Body weight, food, and water intake were measured every two days 
throughout 28 days using a semi-analytical balance. Fasting blood 
glucose levels were monitored on days 0, 7, 14, 21 and 28 using an Accu- 
Chek® Active glucometer (Roche Diagnostics, Mannheim, Germany). At 
the end of the treatments (28 days), the rats were left fasting (12 h), 
anesthetized with isoflurane for blood collection, and sacrificed by 
cervical dislocation. Blood was collected in tubes with or without anti-
coagulants (Vacuplast®collect line), and centrifuged at 1900g for 15 
min. The plasma and serum were separated, stored at − 20 ◦C, and used 
for biochemical analysis. The whole pancreas was excised and washed 
with cold saline, dried, and weighed. Part of the tissue was sliced and 
stored at − 80 ◦C while the remainder was used in the histological 
examination. 
2.6. Biochemical analysis 
Fasting blood glucose was estimated in plasma. Total cholesterol 
(TC), triacylglycerol (TG), high density lipoprotein cholesterol (HDL-C), 
creatinine, urea, albumin, total protein, aspartate aminotransferase 
(AST), and alanine aminotransferase (ALT) were estimated in serum by 
diagnostic kit (In Vitro Diagnóstica Ltda, Itabira, MG, Brazil). Low 
density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein 
cholesterol (VLDL-C) were calculated according to Friedewald, Levy, 
and Fredrickson (1972). 
Table 1 
Diet composition and profile of fatty acids.  
Ingredients (g kg− 1 of 
diet)* 
High Fat 
Diet 
(HFD) 
Standard Diet 
(AIN93M) 
AKO Low 
dose (Diet 
1) 
AKO High 
dose (Diet 
2) 
Casein 335.0 140.0 140.0 140.0 
Cornstarch 78.5 465.7 465.7 195.7 
Dextrinized cornstarch 50.0 155.0 155.0 155.0 
Sucrose 90.0 100.0 100.0 100.0 
Soybean oil 40.0 40.0 0.0 0.0 
Lard 306.0 0.0 0.0 0.0 
Acrocomia aculeata 
kernel oil 
0.0 0.0 40.0 160.0 
Fiber 50.0 50.0 50.0 50.0 
Mineral mix 35.0 35.0 35.0 35.0 
Vitamin mix 10.0 10.0 10.0 10.0 
L-Cystine 1.8 1.8 1.8 1.8 
Choline bitartrate 2.5 2.5 2.5 2.5 
Tert- 
butylhydroquinone 
(TBHQ) 
0.048 0.008 0.008 0.048  
Energy of total kcal 
(percent)     
Carbohydrate 17.0 75.9 75.9 47.9 
Protein 25.1 14.7 14.7 14.7 
Fat 57.9 9.4 9.4 37.4  
Fatty acid 
composition 
(percent)     
Saturated     
Caprilic, C8:0 – – 5.42 ±
0.07 
6.46 ±
0.06 
Capric, C10:0 – – 4.16 ±
0.20 
4.49 ±
0.07 
Lauric, C12:0 – – 40.35 ±
1.88 
41.88 ±
1.60 
Myristic, C14:0 1.31 ±
0.01 
0.11 ± 0.00 9.07 ±
0.09 
9.13 ±
0.29 
Palmitic, C16:0 22.91 ±
0.09 
11.05 ± 0.18 7.66 ±
0.22 
7.17 ±
0.02 
Heptadecanoic, C17:0 0.46 ±
0.00 
0.10 ± 0.00 – – 
Stearic, C18:0 13.49 ±
0.11 
4.41 ± 0.03 3.22 ±
0.18 
2.96 ±
0.19 
Arachidic, C20:0 0.26 ±
0.00 
0.44 ± 0.01 0.19 ±
0.02 
0.19 ±
0.03 
∑ SFA 38.43 16.11 70.07 72.28 
∑ MCFA – – 49.93 52.83  
Monounsaturated 
(MUFA)     
Palmitoleic, C16:1 1.40 ±
0.02 
– – – 
Oleic, C18:1 (ω 9) 32.35 ±
0.06 
24.43 ± 0.11 27.83 ±
1.32 
26.75 ±
1.33 
Cis-11-eicosenic, C20:1 0.64 ±
0.02 
0.25 ± 0.01 0.16 ±
0.00 
0.14 ±
0.02 
∑ MUFA 34.39 24.68 27.99 26.89  
Polyunsaturated 
(PUFA)     
Linoleic, C18:2 (ω 6) 20.03 ±
0.07 
48.12 ± 0.09 4.22 ±
0.19 
3.47 ±
0.16 
Linolenic, C18:3 (ω 3) 1.39 ±
0.01 
5.23 ± 0.00 – – 
∑ PUFA 21.42 53.35 4.22 3.47  
* The diets were formulated in accordance to the American Institute of 
Nutrition (AIN93M) and were produced by the PragSolucões® Co. Company, 
Brazil. Standard diet AIN93M; High Fat Diet – HFD; AKO Low dose: 40 g of AKO 
kg− 1 of diet 1; AKO High dose: 160 g of AKO kg− 1 of diet 2. Abbreviations: AKO - 
Acrocomia aculeata kernel oil; SFA - saturated fatty acids; MCFA - medium chain 
fatty acids. 
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2.7. Enzyme-linked immunosorbent assay for insulin 
Serum insulin levels were measured by enzyme-linked immunosor-
bent assay (ELISA) method using an ultrasensitive rat insulin ELISA kit 
(Crystal Chem. Inc., Downers Grove, IL 60515, USA) in a multi plate 
ELISA reader (Spectrophotometer, Thermo Fisher Scientific Oy, Vantaa 
– Filand). This assay had 100% cross-reactivity to rat insulin. 
2.8. Homeostatic model assessment HOMA-IR and HOMA-β 
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and 
Homeostatic Model Assessment Pancreatic beta cells functional capacity 
(HOMA-β) were calculated according to the following formula by Mat-
thews et al. (1985). 
HOMA − IR = Fasting insulin level (μU/mL)
× Fasting blood glucose (mg/dL)/405  
HOMA− β(%)=20
×Fastinginsulinlevel(μU/mL)/Fastingbloodglucose(mmol/L)
− 3.5  
2.9. Histological examination of the pancreas 
Pancreas samples were fixed in 10% buffered formalin, dehydrated, 
embedded in histological paraffin, sectioned (5 µm) in semi-serials cuts, 
and mounted on glass slides. The tissue sections were deparaffinized, 
rehydrated, and stained with hematoxylin and eosin (H&E). The 
morphometric analyses was performed at different magnifications in the 
non-serial pancreatic sections using hematoxylin and eosin (H&E) to 
estimate (a) the diameter of the pancreatic islets; (b) the number of islets 
in each section of the pancreas; (c) the number of β-cells of the 
pancreatic islets. The diameter of the pancreatic islets were measured for 
each animal (n = 5 animals/group) using 20 digital images (TIFF 8-bit 
color, 3264 × 2448 pixels) 200x magnification from each animal (n 
= 5 animals/group) obtained with a light microscopy (Primo Star ZEISS, 
Germany). Sections were analyzed at 100 µm intervals to avoid 
measuring the same islet twice. The program used to measure the 
diameter of the pancreatic islets was Image J (Image Processing and 
analysis in Java). Quantitative analyses of the pancreatic islets number 
were performed using digital images (Leica DM 500 Microscope) 50x 
magnification from 5 semi-serial sections of 5 μm from each animal (n =
5 animals/group). The β-cells were determined by direct counting 
method at 1000× magnification. Only islets containing 15 or more 
endocrine cells were measured. Stained sections were observed under 
the light microscope (Primo Star ZEISS, Germany) and by a Nikon 
D3100 camera coupled to the microscope. All analyses were performed 
in a double-blind test. 
2.10. Statistical analysis 
Statistical analysis was performed using one-way analysis of variance 
(ANOVA) followed by the Tukey test as the post-test. The results were 
expressed as mean ± standard error of the mean (SEM), using software 
GraphPad Prism® version 5.00. P < 0.05 was statistically significant. 
3. Results 
3.1. Effect of Acrocomia aculeata kernel oil on fasting blood glucose, 
serum insulin and homeostatic model assessment HOMA-IR and HOMA-β 
Fig. 1 shows the levels of fasting blood glucose (A), serum insulin (B), 
HOMA-IR (C) and HOMA-β (D) of the experimental animals. Induction 
of T2DM in the experimental rats was confirmed by presence of a high 
fasting blood glucose level. Moreover, the diabetic induced rats pre-
sented increasing plasma glucose (Fig. 1A) and lower serum insulin 
(Fig. 1B). The diabetic rats treated with AKO, whether DAL or DAH 
groups, showed a significant decrease in the fasting glucose level, 49.5% 
and 47.1% respectively (Fig. 1A). The serum insulin levels and β-cell 
function (HOMA-β) of the DBC group were significantly (p < 0.05) lower 
compared to the NC group. Rats treated with AKO in both DAL and DAH 
groups recorded significantly (p < 0.05) higher insulin levels and β-cell 
function than the DBC group (Fig. 1B, 1D). Indeed, the NAH group had a 
significantly (p < 0.05) higher insulin level than normal rats (NC) group. 
Fig. 1. Effect of Acrocomia aculeata kernel 
oil on fasting blood glucose (A), serum in-
sulin (B), HOMA-IR (C) and HOMA-β (D). 
Data are expressed as mean ± SEM (n = 8). 
Means with different superscripts within the 
row are significantly different (p < 0.05). 
One-way ANOVA followed by Tukey post- 
hoc test. NC: normal control diet (Standard 
diet AIN93M); DBC: diabetic control diet 
(Standard diet AIN93M); DAL: Diabetic rats 
+ low dose − 40 g of AKO kg− 1 of diet 1; 
DAH: Diabetic rats + high dose − 160 g of 
AKO kg− 1 of diet 2; NAH: Non-diabetic rats 
+ high dose − 160 g of AKO kg− 1 of diet 2.   
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HOMA-IR of diabetic rats showed a significant elevation (p < 0.05), but 
the insulin resistance in both DAL and DAH groups improved (Fig. 1C). 
3.2. Effect of AKO on fasting lipids 
The levels of lipid profiles in the control and experimental groups 
were shown in Table 2. In this study, the levels of TC, TG, LDL-C and 
VLDL-C in the DBC group were significantly higher (p < 0.05) and the 
level of HDL-C was significantly lower (p < 0.05) in comparison to NC 
group. On the other hand, treatment with AKO for 4 weeks in diabetic 
rats restored lipid serum profile compared to the DBC group. The TC 
level was the only one not restored. 
3.3. Hepatic and renal function markers 
Table 3 shows significant increase (p < 0.05) in the activities of 
serum AST and ALT of the DBC group compared to NC group. At the end 
of the experimental period, a significant decrease of the AST and ALT 
serum levels in the DAL and DAH groups, compared to DBC group, was 
observed. No significant differences (p > 0.05) in the serum levels of 
creatinine and total protein of all experimental groups were seen. 
However, urea levels increased significantly (p < 0.05) in all diabetic 
groups (DBC, DAL and DAH) compared to the NC and NAH groups. In 
addition, albumin levels were lower in the DAH and NAH groups at the 
end of the experimental period. 
3.4. Morphometric pancreatic analysis 
The results of the morphometric analysis revealed a significant 
reduction in the islet area and number in all T2DM rats compared to NC 
group (Fig. 2 A, B). The number of β-cells/islet was reduced in the DBC 
group, however in the DAL and DAH groups showed a significant in-
crease (p < 0.05) (Fig. 2C). 
4. Discussion 
In this study, T2DM was induced in Wistar rats fed with a high fat 
diet (HFD) for three weeks followed by a low dose of streptozotocin 
(STZ) (Nunes et al., 2018). HFD leads to insulin resistance in peripheral 
tissues due to fat deposit, known as lipotoxicity. Low STZ dose partially 
damages pancreatic beta cells leading to the breakage of DNA strands. 
Cell death is related to alkylation of DNA and, consequently, an increase 
in blood sugar level (Elsner, Guldbakke, Tiedge, Munday, & Lenzen, 
2000). Both HFD and STZ mimic the human syndrome T2DM (Reed 
et al., 2000; Srinivasan, Viswanad, Asrat, Kaul, & Ramarao, 2005). 
The reduction of blood glucose level is the primary therapeutic goal 
for controlling diabetes. In the present study, the blood glucose level of 
diabetic rats was significantly decreased when treated with Acrocomia 
aculeata kernel oil (AKO), as shown by biochemical analysis (Fig. 1A). 
The maintenance of normal glycemia is paramount to reducing the risk 
of pathogenesis related to T2DM at the levels of macrovascular com-
plications (coronary artery disease and peripheral arterial disease) and 
microvascular complications (chronic kidney disease – nephropathy, 
retinopathy and neuropathy) (Fowler, 2008; Rangel, Rodrigues, & De 
Sá, 2019). 
The insulin sensitivity and β-cell function are estimated according to 
the HOMA model based on fasting plasma insulin and glucose concen-
tration (Matthews et al., 1985). In our work, diets with added AKO were 
shown to increase the serum insulin, reduced insulin resistance, and 
augmented pancreatic β function, as the HOMA-IR and HOMA-β data 
show. Findings were corroborated by morphometric pancreatic data 
that showed a higher number of β-cells in the diabetic rats with AKO. 
Ananda Prabu, Kumarappan, Christudas, and Kalaichelvan, (2012) 
evaluated the effect of bioactive phytochemical from Biophytum sensiti-
vum aqueous solution for 28 days in T2DM Wistar rats and demonstrated 
the significant elevation of plasma insulin is probably related to the 
stimulation of insulin secretion from the existing pancreatic β cells. 
Therefore, the improvement of insulin sensitivity is an important ther-
apeutic approach to treat type 2 diabetes. 
The mass loss and functionality of pancreatic β-cells has been one of 
the major concerns in the pathogenesis of T2DM (Duru et al., 2020). 
Therefore, a therapeutic strategy to prevent the progression of T2DM is 
to maintain the functionality and the mass of β-cells (Aguayo-Mazzucato 
& Bonner-Weir, 2018). 
In experimental animal model, Pujol et al., (2018) evaluated the 
beneficial effects of medium chain triglycerides (MCT) on β-cells and 
demonstrated that this could be a potential approach to treat and pre-
vent T2DM because they are related to the improvement of glycemia in 
aged rats via higher insulin secretion. 
The mechanisms encompassed in the beta-cell amelioration func-
tionality, due to the higher MCFAs availability in the diet, could be 
related to three different metabolic processes. MCFAs are involved in 
both mitochondrial function improvement and the boost of the expres-
sion of genes linked to beta-cell function and insulin biogenesis (Pujol 
et al., 2018). In that report, MCFA-C10 promoted the expression of the 
gene GPR40, which leverages glucose insulin secretion in pancreatic 
beta-cells, and MCFA-C8 spurred mitochondrial ketogenesis. Those 
findings came out to the conclusion that MCFA offers a therapeutic 
Table 2 
Effect of Acrocomia aculeata kernel oil on serum lipid profile.   
Experimental Groups1 
Parameters NC DBC DAL DAH NAH 
Serum (mg/ 
dL)      
Total 
cholesterol 
71.21 ±
2.35b 
100.5 ±
4.80a 
92.79 ±
2.27a 
96.82 ±
6.07a 
81.64 ±
2.74b 
Triacylglycerol 83.03 ±
2.72b 
181.91 ±
3.85a 
88.54 ±
3.76b 
89.31 ±
8.64b 
82.94 ±
5.54b 
HDL-C 45.60 ±
4.01a 
21.82 ±
1.30b 
47.74 ±
3.32a 
48.21 ±
5.00a 
47.67 ±
2.37a 
LDL-C 11.28 ±
1.69c 
42.00 ±
0.82a 
27.35 ±
2.85b 
30.75 ±
1.85b 
17.38 ±
2.53c 
VLDL-C 16.61 ±
0.54b 
36.38 ±
0.77a 
17.70 ±
0.75b 
17.86 ±
1.73b 
16.59 ±
1.11b 
Data are expressed as mean ± SEM (n = 8). Means with different superscripts 
within the row are significantly different (p < 0.05). One-way ANOVA followed 
by Tukey post-hoc test. NC: normal control diet (Standard diet AIN93M); DBC: 
diabetic control diet (Standard diet AIN93M); DAL: Diabetic rats + low dose −
40 g of AKO kg− 1 of diet 11; DAH: Diabetic rats + high dose − 160 g of AKO kg− 1 
of diet 2; NAH: Non-diabetic rats + high dose − 160 g of AKO kg− 1 of diet 22. 
Table 3 
Effect of Acrocomia aculeata kernel oil on serum biochemical parameters.   
Experimental groups1 
Parameters NC DBC DAL DAH NAH 
AST (U/L) 81.85 ±
8.57b 
132.9 ±
1.22a 
72.31 ±
6.60b 
80.77 ±
7.25b 
72.24 ±
7.32b 
ALT (U/L) 56.97 ±
3.26b 
82.24 ±
6.32a 
48.07 ±
6.24b 
57.33 ±
6.07b 
26.69 ±
1.58c 
Creatinine 
(mg/dL) 
0.45 ±
0.02a 
0.51 ±
0.01a 
0.41 ±
0.01a 
0.43 ±
0.02a 
0.44 ±
0.04a 
Urea (mg/dL) 41.25 ±
3.28b 
80.44 ±
2.50a 
84.31 ±
1.51a 
90.24 ±
4.54a 
33.90 ±
1.55b 
Total Protein 
(g/dL) 
5.57 ±
0.16a 
5.64 ±
0.27a 
6.13 ±
0.28a 
5.59 ±
0.13a 
6.25 ±
0.13a 
Albumin (g/ 
dL) 
3.97 ±
0.12a 
4.17 ±
0.13a 
4.20 ±
0.14a 
3.44 ±
0.10b 
3.65 ±
0.09b 
Data are expressed as mean ± SEM (n = 8). Means with different superscripts 
within the row are significantly different (p < 0.05). One-way ANOVA followed 
by Tukey post-hoc test. NC: normal control diet (Standard diet AIN93M); DBC: 
diabetic control diet (Standard diet AIN93M); DAL: Diabetic rats + low dose −
40 g of AKO kg− 1 of diet 1; DAH: Diabetic rats + high dose − 160 g of AKO kg− 1 
of diet 2; NAH: Non-diabetic rats + high dose − 160 g of AKO kg− 1 of diet 22. 
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advantage in the preservation of β-cell function as part of a preventative 
strategy against diabetes in at risk population. The third mechanism 
involves cell death due to the apoptosis process. MCFAs can play a 
protective role in beta cells because they do not induce the activity of the 
caspase-3 protease that is involved in the apoptosis process. While 
LCFAs showed a toxic effect on beta cells in parallel with increased 
caspase-3 activity (von Hanstein, Lenzen & Plötz, 2020). 
Montgomery et al., (2013) demonstrated, in a study using mice 
model, that MCFA improves glucose tolerance, augments energy 
expenditure, and reduces adiposity in comparison to LCFA. In a study 
with humans carrying type 2 diabetic that consumed 18 g MCT per day 
for 90 days, reduced HOMA-IR, fasting insulin level and body weight 
when compared with the LCT group (Han et al., 2007). 
Type 2 DM is also characterized by metabolic disorders including 
alterations in the levels of triglycerides, total cholesterol, and lipopro-
teins. In this study, it was also observed an increase in serum TG, TC, 
LDL-C and VLDL-C fractions along with a decreased HDL-C level in the 
diabetic control group. The HDL-C levels in diabetic and non-diabetic 
rats fed with 40 g (low dose) and 160 g (high dose) of AKO kg− 1, 
were found to be higher compared to the diabetic control group, an 
indication of a beneficial effect of the AKO. An increase in HDL-C usually 
results in decreased risk of coronary diseases (Park et al., 2019). While 
LDL-C levels were decreased in both DAL and DAH treatments showing a 
further beneficial effect of AKO. 
Several studies have reported LDL-C as the most dangerous lipid and 
its oxidation increases its penetration in the arterial walls what results in 
the formation of atherosclerotic plaque lesions (Marinangeli, Varady, & 
Jones, 2006; Poznyak et al., 2020). In experiments with Sprague–Daw-
ley rats, fed a diet containing virgin coconut oil (rich in lauric acid) for 
45 days, showed an increase in HDL-C while LDL-C fraction decreased 
(Nevin & Rajamohan, 2004). 
In addition, the serum total cholesterol in both diabetic control group 
and diabetic treatment with AKO were higher than the non-diabetic 
groups, indicating that AKO did not have any effect on the levels of 
total cholesterol. Similar results were obtained by Siddalingaswamy, 
Rayaorth, & Khanum, (2011), when diabetic rats were fed with cold 
virgin coconut oil. 
Diet containing MCT oil reduced hepatic lipid synthesis by 
decreasing the activity of lipogenic enzymes and increasing hepatic 
lipolytic enzymes, consequently lowering serum TG (Schönfeld & 
Wojtczak, 2016). Higher levels of serum HDL-C in animals fed with MCT 
oil is related to the functionality of LDL receptors (Fernandez & West, 
2005). LDL receptors are glycoproteins that recognize apoprotein B and 
it is controlled by glycosylation mechanism (Betteridge, 1989). 
To evaluate possible hepatic dysfunction in T2DM rats serum activity 
of both alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) were measured, high level of these markers indicate leakage from 
the hepatocytes into the bloodstream (Subramanian et al., 2015; Pris-
cilla, Jayakumar, & Thirumurugan, 2015). 
Table 3 shows significant increase in the activities of serum AST 
(62.4%) and ALT (44.3%) in the DBC group compared with NC group. 
Our results pointed out a considerable increase in both enzyme con-
centrations in rats induced to T2DM, this indicates liver damage, caused 
by STZ action, however diabetic rats fed with AKO showed reduced liver 
damage in both, low and high AKO dose. 
In our previous report, it was demonstrated body weight loss in 
T2DM rats, this could be explained from two different point of view, the 
first could be due to lipolysis leading to reduction of adipose tissue, the 
second possibility might be related to proteolysis diminishing muscle 
tissue (Nunes et al., 2018). 
In this respect, both creatinine and total protein serum concentra-
tions were not altered, whereas urea levels increased significatively in 
all diabetic groups, showing higher proteolysis compared to the non- 
diabetic rats leading to ammonium production during the deamination 
steps which is immobilized into urea. Whereas a drop in concentration of 
serum albumin in both groups DAH and NAH was observed. This finding 
probably could be interpreted based on the assumption that determi-
nation of serum albumin using the bromocresol green method, in a 
condition of high levels of circulating fatty acids, underestimates albu-
min concentration. 
As far as we know this is the first scientific evidence of AKO as hy-
poglycemic agent, protecting beta cells, improving their function ability, 
and acting as hepatoprotective. From our point of view this research 
opens a new avenue to pursue functional food for improving life con-
dition and health of the population that utilizes the food potential of 
Fig. 2. Pancreatic morphometric analysis. Area of pancreatic islets (A), Num-
ber of pancreatic islets per pancreas area (B), Number of pancreatic β-cells (C). 
Data are expressed as mean ± SEM of values from 5 rats of each group. Means 
with different superscripts within the row are significantly different (p < 0.05). 
One-way ANOVA followed by Tukey post-hoc test. NC: normal control diet 
(Standard diet AIN93M); DBC: diabetic control diet (Standard diet AIN93M); 
DAL: Diabetic rats + low dose − 40 g of AKO kg− 1 of diet 1; DAH: Diabetic rats 
+ high dose − 160 g of AKO kg− 1 of diet 2; NAH: Non-diabetic rats + high dose 
− 160 g of AKO kg− 1 of diet 2. 
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biodiversity in general, mainly subjects carrying diabetic type 2. 
Considering the establishment of the macauba value chain, these 
findings are very worthy, as kernel oil may be directed to a niche market 
for products with high added value, which is eager for products that are 
proven efficient and produced in a sustainable manner. 
In summary, our data demonstrated that AKO fed to T2DM rats 
exerted hypoglycemic action, stimulated insulin secretion, improved 
pancreatic β cell function (HOMA-β), and decreased insulin resistance 
(HOMA-IR) it also had a positive effect on pancreatic islet morphology 
and on the number of β-cells. In addition, AKO decreased LDL-C and 
augmented HDL-C levels, which could reduce the risk of chronic diseases 
related to T2DM syndrome. Furthermore, AKO also had a hepatic pro-
tector effect lowering the levels of serum AST and ALT. 
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